Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cingal in knee osteoarthritis (39-week extension)
NCT03390036Phase 3Completed
- Sponsor
- Anika Therapeutics
- Start
- Dec 2017
- Primary completion
- Jul 2018
- Modality
- Injectable Hydrogels, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of triamcinolone hexacetonide + hyaluronic acid in knee osteoarthritis (OA), sponsored by Anika Therapeutics. Started Dec 2017; status: completed.
02
Drugs
triamcinolone hexacetonide + hyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03390036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390036.